GlassScriptPhysician profile
Michael L Ernst
NPI 1386039378
$2,108.48
in general payments reported to CMS, 2019-2025
9 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Pediatric Urology provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $174 · 2022: $241 · 2023: $84.07 · 2024: $1,350 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,350 · Food and Beverage: $181 · Education: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,350.00 |
| Food and Beverage | $180.50 |
| Education | $162.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,350.00 | 2024 | Rivfloza |
| Palette Life Sciences, INC. | $267.72 | 2021-2022 | |
| Intuitive Surgical, INC. | $162.88 | 2025 | |
| Coloplast Corp | $147.38 | 2022 | |
| Karl Storz Endoscopy-America | $84.07 | 2023 | |
| Dentsply Ih Ab | $46.86 | 2025 | Lofric |
| Immunitybio, INC. | $19.23 | 2025 | |
| Endo USA, INC. | $15.19 | 2025 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $15.15 | 2025 | Erleada |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ernst listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.